Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Endoscope Final Guidance Calls For Backflow Prevention

Executive Summary

Irrigation accessories used with endoscopes pose a risk of cross-contamination when used on multiple patients. An FDA final guidance will require these devices to include a backflow-prevention valve to mitigate the risk.

You may also be interested in...



US FDA wants reusable device makers to validate reprocessing instructions

The US Food and Drug Administration has issued final guidance to help manufacturers of reusable medical devices develop safer products, especially those that pose a greater risk of infection1-3

To Mitigate Endoscope Contamination Risk, Stop Backflows And Reprocess, FDA Says

A draft guidance recommends prevention of backflow in flexible gastrointestinal endoscopes and reprocessing or discarding endoscopic devices with distal one-way valves to mitigate cross-contamination risks.

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104147

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel